Skip to main content
logo
AngioDynamics, Inc. (ANGO)
NASDAQ: ANGO · Real-Time Price · USD
11.12
+0.07 (0.63%)
At close: Oct 8, 2025, 4:00 PM EDT
11.17
+0.05 (0.45%)
After-hours: Oct 8, 2025, 6:58 PM EDT

AngioDynamics Revenue

AngioDynamics had revenue of $75.71M in the quarter ending August 31, 2025, with 12.18% growth. This brings the company's revenue in the last twelve months to $300.72M, up 2.73% year-over-year. In the fiscal year ending May 31, 2025, AngioDynamics had annual revenue of $292.50M, down -3.76%.

Revenue (ttm)
$300.72M
Revenue Growth
+2.73%
P/S Ratio
1.52
Revenue / Employee
$445,508
Employees
675
Market Cap
458.14M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
May 31, 2025292.50M-11.42M-3.76%
May 31, 2024303.91M-34.84M-10.28%
May 31, 2023338.75M22.53M7.13%
May 31, 2022316.22M25.21M8.66%
May 31, 2021291.01M26.85M10.17%
May 31, 2020 Pro Pro Pro
May 31, 2019 Pro Pro Pro
May 31, 2018 Pro Pro Pro
May 31, 2017 Pro Pro Pro
May 31, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson90.63B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings

ANGO News

More News